Clinical trials
Completed Phase 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 1 |
| 2007 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| Fred Hutchinson Cancer Center | 9 |
| Mayo Clinic | 3 |
| Case Comprehensive Cancer Center | 2 |
| Goethe University | 2 |
| AIDS Malignancy Consortium | 1 |
| City of Hope Medical Center | 1 |
| Columbia University | 1 |
| Daiichi Sankyo Co., Ltd. | 1 |
| Deepa Jagadeesh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 52 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 35 |
| Lymphoma, Large B-Cell, Diffuse | 32 |
| Burkitt Lymphoma | 31 |
| Lymphoma, Follicular | 31 |
| Lymphoma, Large-Cell, Anaplastic | 31 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 30 |
| Lymphoma, Non-Hodgkin | 30 |
| Immunoblastic Lymphadenopathy | 29 |
| Lymphoma, B-Cell, Marginal Zone | 29 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.